Key Takeaway: The article announces the pivotal results from the BOND-003 study to be presented at AUA 2024. Details regarding the study's findings or implications are not provided in the text. The announcement is part of a broader communication strategy for the event.
Price reaction · baseline $29.75 (2024-05-22T17:27:00.000Z) · hit during market hours · 1 other CGON headline(s) in the window, move may be shared
day 0 close · peak
+3.6%
Market Sentiment Analysis
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial advice